Skip to Content

Delcath Systems Inc DCTH Stock Quote

| Rating as of

NASDAQ: DCTH

Market Closed

| Currency in USD

  • Last Close 4.11
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Small Value
  • Day Range 4.02  –  4.19
  • Year Range 2.34  –  7.99
  • Market Cap 62.7864 Mil
  • Volume / Avg 138,659.0 /  2.2 Mil
  • Price / Sales 16.81
  • Price / Book
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis DCTH

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics DCTH

Company Profile DCTH

Business Description

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Contact
1633 Broadway, Suite 22C
New York, NY, 10019
Industry Medical Devices
Employees 52

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Delcath Systems Inc

XNAS: DCTH

Galera Therapeutics Inc Ordinary Shares

XNAS: GRTX

Panacea Acquisition Corp Ordinary Shares - Class A

XNYS: NUVB

Sana Biotechnology Inc Ordinary Shares

XNAS: SANA
Price
4.110.183.99
Currency
USDUSDUSD
Change
+$0.09 (2.24%) $0.00 (1.23%) +$0.02 (0.50%)
Market Cap
62.79 Mil7.92 Mil785.80 Mil
Industry
Medical Devices Biotechnology Biotechnology Biotechnology
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Delcath Systems Inc Stock

No. DCTH does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

DCTH’s market cap is 62.79 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

DCTH’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

DCTH’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare DCTH’s historical performance against its industry peers and the overall market.